...
首页> 外文期刊>European journal of gastroenterology and hepatology >Intestinal permeability in liver cirrhosis: relationship with severe septic complications.
【24h】

Intestinal permeability in liver cirrhosis: relationship with severe septic complications.

机译:肝硬化的肠道通透性:与严重的脓毒症并发症相关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: Patients with liver cirrhosis are at high risk of severe septic complications such as spontaneous bacterial peritonitis (SBP) and bacteraemia. The aims of this study were to assess intestinal permeability in patients with liver cirrhosis and to search for a relationship between an impaired intestinal permeability and the occurrence of severe septic complications. METHODS: Intestinal permeability was assessed in a group of 80 cirrhotic patients (Child A, n = 13; Child B, n = 26; Child C, n = 41) and 28 healthy control subjects. A severe septic complication (bacteraemia and/or SBP) occurred in 16 patients, within 10 days before (n = 8 cases) or after (n = 8 cases) the test was performed. Lactulose (LAC) 10 g was given orally together with mannitol (MAN) 5 g, and urinary excretion rates were determined. RESULTS: Urinary mannitol excretion (MAN%) was lower while the LAC/MAN ratio was higher in patients than in control subjects (P < 0.001); these abnormalities were more marked in Child C patients (Child C patients vs control subjects: MAN%, 8.20 +/- 0.79 vs 14.59 +/- 0.58, P < 0.001; LAC/MAN, 0.066 +/- 0.026 vs 0.017 +/- 0.001, P < 0.02). When compared with non-infected patients, septic patients had a lower MAN% and an increased LAC/ MAN ratio (5.45 +/- 1.12 vs 9.83 +/- 0.87, P < 0.02; 0.130 +/- 0.063 vs 0.029 +/- 0.005, P < 0.02). CONCLUSION: Although the main mechanism involved in the decrease in MAN% is likely a reduction in area of the intestinal absorptive surface, these results argue in favour of an increased intestinal permeability in liver cirrhosis, especially in patients with severe infectious complications. The impairment of intestinal function barrier may contribute to severe septic complications in these patients.
机译:目的:肝硬化患者极有可能发生严重的感染性并发症,例如自发性细菌性腹膜炎(SBP)和菌血症。这项研究的目的是评估肝硬化患者的肠道通透性,并寻找肠通透性受损与严重脓毒症并发症之间的关系。方法:对80例肝硬化患者(儿童A,n = 13;儿童B,n = 26;儿童C,n = 41)和28名健康对照者进行了肠通透性评估。在进行测试前(n = 8例)或之后(n = 8例)的10天内,有16名患者发生了严重的脓毒症并发症(菌血症和/或SBP)。口服10克乳果糖(LAC)和5克甘露醇(MAN),测定尿排泄率。结果:与对照组相比,患者的尿液甘露醇排泄(MAN%)较低,而LAC / MAN比率较高(P <0.001);这些异常在儿童C患者中更为明显(儿童C患者与对照组:MAN%,8.20 +/- 0.79 vs 14.59 +/- 0.58,P <0.001; LAC / MAN,0.066 +/- 0.026 vs 0.017 +/- 0.001,P <0.02)。与未感染的患者相比,败血病患者的MAN%较低,LAC / MAN比率增加(5.45 +/- 1.12 vs 9.83 +/- 0.87,P <0.02; 0.130 +/- 0.063 vs 0.029 +/- 0.005 ,P <0.02)。结论:尽管降低MAN%的主要机制可能是减少肠道吸收表面的面积,但这些结果表明,肝硬化患者尤其是严重感染并发症患者的肠道通透性增加。肠功能障碍的损害可能导致这些患者严重的脓毒症并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号